Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
226 GBX | -0.66% | 0.00% | +16.37% |
May. 21 | PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug | AN |
May. 20 | PureTech Health Opens $100 Million Buyback Program | MT |
Financials (USD)
Sales 2024 * | 58.9M | Sales 2025 * | 36.75M | Capitalization | 782M |
---|---|---|---|---|---|
Net income 2024 * | -145M | Net income 2025 * | -191M | EV / Sales 2024 * | 7.25 x |
Net cash position 2024 * | 355M | Net cash position 2025 * | 360M | EV / Sales 2025 * | 11.5 x |
P/E ratio 2024 * |
-3.9
x | P/E ratio 2025 * |
-3.62
x | Employees | 90 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.22% |
Latest transcript on PureTech Health plc
1 day | -0.66% | ||
Current month | +4.63% | ||
1 month | +3.67% | ||
3 months | +13.00% | ||
6 months | +44.50% | ||
Current year | +16.37% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Elenko
FOU | Founder | 51 | 15-05-31 |
Bharatt Chowrira
CEO | Chief Executive Officer | 59 | 17-03-01 |
Allison Talbot
IRC | Investor Relations Contact | - | 16-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 81 | 13-12-31 | |
Bharatt Chowrira
CEO | Chief Executive Officer | 59 | 17-03-01 |
Robert Langer
FOU | Founder | 75 | 15-05-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 226 | -0.66% | 286,341 |
24-05-24 | 227.5 | +0.89% | 119,636 |
24-05-23 | 225.5 | -0.44% | 240,631 |
24-05-22 | 226.5 | +0.22% | 238,878 |
24-05-21 | 226 | -1.09% | 284,478 |
Delayed Quote London S.E., May 28, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.37% | 787M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- PRTC Stock